US3928344A
(en)
*
|
1971-12-27 |
1975-12-23 |
Degussa |
Phenylenediamine-s-triazines
|
IT1060458B
(it)
*
|
1975-12-18 |
1982-08-20 |
Chimosa Chimica Organica Spa |
Composti piperidil triazinici adatti per la stabilizzazione di polimeri sintetici e procedimento per la loro preparazione
|
DE3006803A1
(de)
*
|
1980-02-23 |
1981-09-03 |
Bayer Ag, 5090 Leverkusen |
Vulkanisationsbeschleuniger auf basis von melaminderivaten, melaminderivate enthaltende kautschukmassen sowie ein verfahren zur vulkanisation von kautschuken
|
DE3401675A1
(de)
*
|
1984-01-19 |
1985-07-25 |
Bayer Ag, 5090 Leverkusen |
Neue polyamine und ein verfahren zu ihrer herstellung
|
DE3438694A1
(de)
*
|
1984-10-23 |
1986-04-24 |
Basf Ag, 6700 Ludwigshafen |
Neue amidoalkylmelamine und aminoalkylmelamine und verfahren zu ihrer herstellung
|
EP0945447A1
(en)
*
|
1998-03-27 |
1999-09-29 |
Janssen Pharmaceutica N.V. |
Trisubstituted 1,3,5-triazine derivatives for treatment of HIV infections
|
SI1129079T1
(sl)
|
1998-11-10 |
2006-06-30 |
Janssen Pharmaceutica Nv |
2,4-disubstituirani triazinski derivati z anti-HIV aktivnostjo
|
US6225378B1
(en)
*
|
1999-07-01 |
2001-05-01 |
Industrial Technology Research Institute |
Triazine hardener and epoxy composition containing the same
|
JP4919566B2
(ja)
*
|
1999-09-24 |
2012-04-18 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
抗ウイルス組成物
|
US6660731B2
(en)
*
|
2000-09-15 |
2003-12-09 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
US7473691B2
(en)
*
|
2000-09-15 |
2009-01-06 |
Vertex Pharmaceuticals Incorporated |
Pyrazole compounds useful as protein kinase inhibitors
|
JP4105948B2
(ja)
*
|
2000-09-15 |
2008-06-25 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼインヒビターとして有用なピラゾール化合物
|
KR100909665B1
(ko)
*
|
2000-12-21 |
2009-07-29 |
버텍스 파마슈티칼스 인코포레이티드 |
단백질 키나제 억제제로서 유용한 피라졸 화합물 및 이를 포함하는 약제학적 조성물
|
RU2004126671A
(ru)
*
|
2002-02-06 |
2005-04-10 |
Вертекс Фармасьютикалз Инкорпорейтед (Us) |
Гетероарилсоединения, полезные в качестве ингибиторов gsk-3
|
WO2003078427A1
(en)
*
|
2002-03-15 |
2003-09-25 |
Vertex Pharmaceuticals, Inc. |
Azolylaminoazines as inhibitors of protein kinases
|
MY141867A
(en)
*
|
2002-06-20 |
2010-07-16 |
Vertex Pharma |
Substituted pyrimidines useful as protein kinase inhibitors
|
NZ538426A
(en)
|
2002-08-02 |
2007-05-31 |
Vertex Pharma |
Pyrazole compositions useful as inhibitors of glycogen synthase kinase-3 (GSK-3)
|
US7601718B2
(en)
*
|
2003-02-06 |
2009-10-13 |
Vertex Pharmaceuticals Incorporated |
Compositions useful as inhibitors of protein kinases
|
AU2004297235A1
(en)
*
|
2003-12-04 |
2005-06-23 |
Vertex Pharmaceuticals Incorporated |
Quinoxalines useful as inhibitors of protein kinases
|
WO2006024175A1
(en)
*
|
2004-09-03 |
2006-03-09 |
Prometic Biosciences Inc. |
2,4,6-TRIAMINO-S-TRIAZINE-BASED COMPOUNDS WHICH BIND TO THE TAIL (Fc) PORTION OF IMMUNOGLOBULINS AND THEIR USE
|
ITMI20050222A1
(it)
*
|
2005-02-15 |
2006-08-16 |
Milano Politecnico |
Lipidi cationici per la trasfezione di acidi nucleici
|
AU2006279376B2
(en)
*
|
2005-08-18 |
2011-04-14 |
Vertex Pharmaceuticals Incoporated |
Pyrazine kinase inhibitors
|
ES2533241T3
(es)
*
|
2005-11-03 |
2015-04-08 |
Vertex Pharmaceuticals Incorporated |
Aminopirimidinas útiles como inhibidores de cinasas
|
DE602007004750D1
(de)
*
|
2006-11-02 |
2010-03-25 |
Vertex Pharma |
Als inhibitoren von proteinkinasen geeignete aminopyridine und aminopyrimidine
|
JP2010513567A
(ja)
*
|
2006-12-19 |
2010-04-30 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
プロテインキナーゼの阻害剤として有用なアミノピリミジン
|
NZ579446A
(en)
*
|
2007-03-09 |
2012-02-24 |
Vertex Pharma |
Aminopyrimidines useful as inhibitors of protein kinases
|
NZ579485A
(en)
*
|
2007-03-09 |
2012-02-24 |
Vertex Pharma |
Aminopyrimidines useful as inhibitors of protein kinases
|
MX2009009592A
(es)
|
2007-03-09 |
2009-11-10 |
Vertex Pharma |
Aminopiridinas utiles como inhibidores de proteinas cinasas.
|
JP2010523700A
(ja)
|
2007-04-13 |
2010-07-15 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
キナーゼインヒビターとして有用なアミノピリミジン
|
CN101801959A
(zh)
*
|
2007-05-02 |
2010-08-11 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的氨基嘧啶类化合物
|
MX2009011810A
(es)
*
|
2007-05-02 |
2010-01-14 |
Vertex Pharma |
Tiazoles y pirazoles utiles como inhibidores de cinasa.
|
AU2008247595A1
(en)
*
|
2007-05-02 |
2008-11-13 |
Vertex Pharmaceuticals Incorporated |
Aminopyrimidines useful as kinase inhibitors
|
CN101687852A
(zh)
*
|
2007-05-24 |
2010-03-31 |
沃泰克斯药物股份有限公司 |
可用作激酶抑制剂的噻唑类和吡唑类化合物
|
AU2008282156B2
(en)
*
|
2007-07-31 |
2014-07-17 |
Vertex Pharmaceuticals Incorporated |
Process for preparing 5-fluoro-1H-pyrazolo [3, 4-b] pyridin-3-amine and derivatives thereof
|
EP2323622A1
(en)
*
|
2008-09-03 |
2011-05-25 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical formulations comprising the same
|
US20120121515A1
(en)
|
2009-03-13 |
2012-05-17 |
Lenny Dang |
Methods and compositions for cell-proliferation-related disorders
|
TWI598337B
(zh)
|
2009-06-29 |
2017-09-11 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
EP3064595B1
(en)
|
2009-10-21 |
2019-02-27 |
Agios Pharmaceuticals, Inc. |
Methods for cell-proliferation-related disorders
|
KR101873543B1
(ko)
|
2011-05-03 |
2018-07-02 |
아지오스 파마슈티컬스 아이엔씨. |
치료에 사용하기 위한 피루베이트 키나아제 활성제
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
IN2014MN00381A
(xx)
*
|
2011-08-04 |
2015-06-19 |
Colourtex Ind Ltd |
|
CN103874723B
(zh)
*
|
2011-08-12 |
2015-10-21 |
宇部兴产株式会社 |
聚酰亚胺前体,聚酰亚胺,聚酰亚胺膜,和用于制造其的三嗪化合物的制备方法
|
CN115521264A
(zh)
|
2012-01-06 |
2022-12-27 |
法国施维雅药厂 |
治疗活性化合物及其使用方法
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
US9556312B2
(en)
*
|
2012-05-14 |
2017-01-31 |
National University Corporation Iwate University |
Polyimide precursor, polyimide, polyimide film, polyimide metal laminate, and polyimide solution
|
WO2014062511A1
(en)
|
2012-10-15 |
2014-04-24 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
WO2015003360A2
(en)
*
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
CN111087353B
(zh)
*
|
2013-07-11 |
2023-10-24 |
法国施维雅药厂 |
治疗活性化合物及其使用方法
|
US9579324B2
(en)
|
2013-07-11 |
2017-02-28 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
CN105593215B
(zh)
|
2013-07-11 |
2019-01-15 |
安吉奥斯医药品有限公司 |
用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
EA032070B1
(ru)
|
2013-07-11 |
2019-04-30 |
Аджиос Фармасьютикалз, Инк. |
Соединения n,6-бис(арил или гетероарил)-1,3,5-триазин-2,4-диамина в качестве ингибиторов мутантов idh2 для лечения ракового заболевания
|
US20150031627A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc |
Therapeutically active compounds and their methods of use
|
KR20220070066A
(ko)
|
2014-03-14 |
2022-05-27 |
아지오스 파마슈티컬스 아이엔씨. |
치료적으로 활성인 화합물의 약제학적 조성물
|
MD3307271T2
(ro)
|
2015-06-11 |
2024-01-31 |
Agios Pharmaceuticals Inc |
Metode de utilizare a activatorilor de piruvat kinază
|
HRP20211790T1
(hr)
|
2015-10-15 |
2022-03-04 |
Les Laboratoires Servier |
Kombinirana terapija za liječenje maligniteta
|
PL3362065T3
(pl)
|
2015-10-15 |
2024-09-16 |
Les Laboratoires Servier |
Terapia skojarzona zawierająca iwosidenib, cytarabinę i daunorubicynę lub idarubicynę do leczenia ostrej białaczki szpikowej
|
CN108640881A
(zh)
*
|
2018-04-26 |
2018-10-12 |
江汉大学 |
一种二胺单体及其合成方法
|
US10980788B2
(en)
|
2018-06-08 |
2021-04-20 |
Agios Pharmaceuticals, Inc. |
Therapy for treating malignancies
|
CN116790213B
(zh)
*
|
2023-07-04 |
2024-02-20 |
江苏特丽亮新材料科技有限公司 |
一种耐高温导电胶及其制备方法
|